PDS Biotechnology (PDSB) Return on Invested Capital (2015 - 2026)
PDS Biotechnology's (PDSB) quarterly Return on Invested Capital came in at 0.04% in Q4 2025, up 55.0% YoY from 0.02% in Q4 2024, and up 58.71% on a QoQ basis from 0.09% in Q3 2025.
PDS Biotechnology (PDSB) Return on Invested Capital (2015 - 2026) Analysis & Trends
PDS Biotechnology (PDSB) has 4 years of Return on Invested Capital data on file, last reported at 0.04% in Q4 2025.
- Quarterly Return on Invested Capital rose 55.0% year-over-year to 0.04% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.04% (up 55.0% YoY) and the FY2025 annual result came in at 2.7%, down 34.0% from the prior year.
- Return on Invested Capital grew to 0.04% in Q4 2025, from 0.09% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.04% in Q4 2025 to a low of 1.67% in Q3 2023.
- A 3-year average of 0.63% and a median of 0.6% in 2025 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2024 — Return on Invested Capital jumped 108 bps — and 2025, when it declined 13 bps.
- Tracing PDSB's Return on Invested Capital over 3 years: stood at 0.86% in 2023, then jumped by 32 bps to 0.59% in 2024, then surged by 94 bps to 0.04% in 2025.
- The last three Return on Invested Capital figures came in at 0.04% (Q4 2025), 0.09% (Q3 2025), and 0.68% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | PDS Biotechnology | 12.02 Mn | 12.02 Mn | - | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.03% |
| Dec 31, 2025 | -0.04% |
| Sep 30, 2025 | -0.09% |
| Jun 30, 2025 | -0.68% |
| Mar 31, 2025 | -0.61% |
| Dec 31, 2024 | -0.59% |
| Sep 30, 2024 | -0.58% |
| Jun 30, 2024 | -0.54% |
| Mar 31, 2024 | -0.64% |
| Dec 31, 2023 | -0.86% |
| Sep 30, 2023 | -1.67% |
| Dec 31, 2015 | -0.07% |